This week: Jessica Smith is joined by James, Belle and Albion VC's Molly Gilmartin.

[01:50] SVB fuelled high-risk, high-reward tech firms. Now health start-ups feel bereft

[10:00] Why do so many biotechs face being kicked off the Nasdaq?

[15:15] How UK healthtechs can get a head start on their US expansion

[28:05] Why investors should pay close attention to the UK’s healthtech sector in 2023

✍️ Apply to be a guest at this form

📖 Learn more about the SomX team at somx.health

🖇 Connect with Jessica on LinkedIn

🖇 Connect with James on LinkedIn

🖇 Connect with Belle on LinkedIn

🖇 Connect with Molly on LinkedIn